z-logo
Premium
Development of real‐time reverse transcriptase polymerase chain reaction methods for human rabies diagnosis
Author(s) -
NadinDavis Susan A.,
Sheen Mary,
Wandeler Alexander I.
Publication year - 2009
Publication title -
journal of medical virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.782
H-Index - 121
eISSN - 1096-9071
pISSN - 0146-6615
DOI - 10.1002/jmv.21547
Subject(s) - virology , rabies virus , rabies , taqman , virus , biology , lyssavirus , primer (cosmetics) , reverse transcriptase , real time polymerase chain reaction , polymerase chain reaction , saliva , viral load , titer , mononegavirales , rhabdoviridae , viral disease , chemistry , gene , paramyxoviridae , genetics , biochemistry , organic chemistry
To improve timely ante‐mortem human rabies diagnosis, methods to detect viral RNA by TaqMan‐based quantitative reverse transcriptase polymerase chain reactions (qRT‐PCRs) have been developed. Three sets of two primers and one internal dual‐labeled probe for each primer set that target distinct conserved regions of the rabies virus N gene were designed and evaluated. Using a collection of 203 isolates representative of the world‐wide diversity of rabies virus, all three primers/probe sets were shown to detect a wide range of rabies virus strains with very few detection failures; the RABVD1 set in particular was the most broadly reactive. These qRT‐PCR assays were shown to be quantitative over a wide range of viral titer and were 100–1,000 times more sensitive than nested RT‐PCR; however, both the standard and real‐time PCR methods yielded concordant results when used to test a collection of archived human suspect samples. The qRT‐PCR assay was employed to monitor virus load in the saliva of a rabies virus‐infected patient undergoing the Milwaukee treatment protocol. However in this case it would appear that reduction of the viral load in the patient's saliva over time did not appear to correlate well with clearance of viral components from the brain. J. Med. Virol. 81:1484–1497, 2009. © 2009 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here